BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3492415)

  • 1. [Cerebral glucose metabolism in presenile dementia of the Alzheimer type--follow-up of therapy with muscarinergic choline agonists].
    Szelies B; Herholz K; Pawlik G; Beil C; Wienhard K; Heiss WD
    Fortschr Neurol Psychiatr; 1986 Nov; 54(11):364-73. PubMed ID: 3492415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of glucose metabolism in Pick's disease].
    Szelies B; Karenberg A
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):393-7. PubMed ID: 3493192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.
    Cutler NR; Haxby JV; Duara R; Grady CL; Kay AD; Kessler RM; Sundaram M; Rapoport SI
    Ann Neurol; 1985 Sep; 18(3):298-309. PubMed ID: 3876805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral blood flow and cerebral oxygen metabolism in patients with dementia of frontal lobe type].
    Kitamura S; Araki T; Sakamoto S; Iio M; Terashi A
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1171-5. PubMed ID: 2085920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
    Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No response to high-dose muscarinic agonist therapy in Alzheimer's disease.
    Mouradian MM; Mohr E; Williams JA; Chase TN
    Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
    Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
    Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
    Heiss WD; Herholz K; Pawlik G; Hebold I; Klinkhammer P; Szelies B
    Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).
    Wettstein A; Spiegel R
    Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.
    Hollander E; Davidson M; Mohs RC; Horvath TB; Davis BM; Zemishlany Z; Davis KL
    Biol Psychiatry; 1987 Sep; 22(9):1067-78. PubMed ID: 3651528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
    Davis R; Raby C; Callahan MJ; Lipinski W; Schwarz R; Dudley DT; Lauffer D; Reece P; Jaen J; Tecle H
    Prog Brain Res; 1993; 98():439-45. PubMed ID: 8248534
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 16. Approaches to cholinergic therapy in Alzheimer's disease.
    Iversen LL
    Prog Brain Res; 1993; 98():423-6. PubMed ID: 8248531
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholinergic precursors in Alzheimer's disease.
    Pomara N; Stanley M
    Lancet; 1982 Nov; 2(8306):1049. PubMed ID: 6127534
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinergic drug studies in dementia and depression.
    Newhouse PA
    Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholinergic treatments for Alzheimer's disease.
    Roberts F; Lazareno S
    Biochem Soc Trans; 1989 Feb; 17(1):76-9. PubMed ID: 2653922
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term choline treatment of memory-impaired elderly patients.
    Ferris SH; Sathananthan G; Reisberg B; Gershon S
    Science; 1979 Sep; 205(4410):1039-40. PubMed ID: 472728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.